Cleared Traditional

K973832 - OPUS HLH CONTROLS

K973832 is the FDA 510(k) clearance for OPUS HLH CONTROLS by Behring Diagnostics, Inc.. It is a Class 1 Toxicology device (product code JJX) cleared through the Traditional 510(k) pathway after a 20-day FDA review.

K973832 · Behring Diagnostics, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1997
Decision
20d
Days
Class 1
Risk

K973832 is an FDA 510(k) clearance for the OPUS HLH CONTROLS. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Behring Diagnostics, Inc. (Westwood, US). The FDA issued a Cleared decision on October 27, 1997 after a review of 20 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.1660 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Behring Diagnostics, Inc. devices

Submission Details

510(k) Number K973832 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 07, 1997
Decision Date October 27, 1997
Days to Decision 20 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 87d · This submission: 20d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 370
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K973832.
REP CHOLESTEROL PROFILE CONTROL-II
K974609 · Helena Laboratories · Jan 1998
ELECSYS CALCHECK VITAMIN B12
K974383 · Boehringer Mannheim Corp. · Dec 1997
SERUM HCG CONTROL SET (NEGATIVE, LOW POSITIVE AND HIGH POSITIVE)
K974108 · Quidel Corp. · Nov 1997
MYOGLOBIN CONTROL SET
K973358 · Boehringer Mannheim Corp. · Oct 1997
WAKO NEFA LINEARITY SET
K973072 · Wako Chemicals USA, Inc. · Sep 1997
ROCHE HEMOGLOBIN A1C CONTROL N AND CONTROL P
K972721 · Roche Diagnostic Systems, Inc. · Aug 1997